tiprankstipranks
Trending News
More News >
Owlet (OWLT)
NYSE:OWLT
US Market

Owlet (OWLT) AI Stock Analysis

Compare
143 Followers

Top Page

OWLT

Owlet

(NYSE:OWLT)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$5.00
▼(-2.72% Downside)
Action:ReiteratedDate:03/13/26
The score is held down primarily by weak financial quality (continued GAAP losses and negative free cash flow) and very bearish technicals (sharp downtrend with deeply weak momentum). These are partially offset by constructive earnings-call signals, including upbeat 2026 growth/EBITDA guidance and subscription traction, but valuation provides limited support given a non-meaningful negative P/E and no dividend.
Positive Factors
Subscription Momentum
Growing subscription base creates recurring revenue and higher lifetime value, improving revenue visibility and reducing reliance on one-time hardware sales. Four quarters of sequential subscriber growth and improving MRR/attach rates indicate durable monetization of the installed base and better unit economics over time.
Sustained ~50% Gross Margins
Consistently high ~50% gross margins imply strong product economics and pricing power in the category. Sustained margins support long-term profitability as scale and subscription mix grow, enabling margin expansion even while the company absorbs external cost pressures like tariffs.
Product Innovation & Market Share Gains
Frequent product launches, strong sell-through and high NPS indicate differentiated offerings and strong channel execution. Rapid market-share gains and registry growth show the brand is capturing consumer preference, which supports sustainable unit growth and strengthens competitive barriers over time.
Negative Factors
Negative Operating & Free Cash Flow
Persistent negative operating and free cash flow indicates the business is not yet self-funding and remains dependent on external capital. Continued cash burn constrains reinvestment, increases financing risk, and could pressure liquidity or strategic initiatives if losses persist.
Tariff-Driven Margin Pressure
Tariffs have materially eroded margins by several hundred basis points, a structural external cost that can persist with ongoing geopolitical uncertainty. That pressure reduces sustainable EBITDA and makes forecasting margins harder, limiting the company's ability to convert revenue growth into consistent GAAP profits.
Derivative Litigation & Governance Overhang
Ongoing derivative litigation and related governance reforms create legal, financial and managerial distraction. Settlement uncertainty and potential governance changes could result in fees, resource diversion, and reputational risk, weakening management flexibility and complicating long-term strategic execution.

Owlet (OWLT) vs. SPDR S&P 500 ETF (SPY)

Owlet Business Overview & Revenue Model

Company DescriptionOwlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.
How the Company Makes MoneyOwlet primarily makes money by selling connected baby monitoring hardware directly to consumers and through retail channels. Key revenue streams include: (1) Product sales of its smart sock wearable infant monitor and companion camera/monitoring devices, which generate the majority of revenue when units are sold through Owlet’s website and third-party retailers/distributors. (2) Software and service-related revenue tied to its connected ecosystem (mobile app and related features). Specific details on paid subscription tiers, pricing, or the exact contribution of services versus hardware are null. (3) International and channel partner sales where revenue is recognized through distributors/retail partners; specific named partnerships and their quantitative impact are null. Overall earnings are driven by unit volume, average selling prices, channel mix (direct-to-consumer vs. retail/wholesale), and ongoing customer engagement with the connected product ecosystem; precise breakdown percentages by stream are null.

Owlet Earnings Call Summary

Earnings Call Date:Mar 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The call emphasized multiple material achievements — record annual revenue, record full-year gross margin and adjusted EBITDA, strong product launches (Dream Sight) and subscription momentum (110k+ paying subscribers), significant market share gains and international regulatory progress — and management provided a confident 2026 growth outlook. Near-term headwinds include meaningful tariff-related margin pressure, Q4 adjusted EBITDA softness relative to the prior year, a light Q1 guide due to seasonality and tough comps, and ongoing external uncertainties (tariffs, geopolitical risk, regulatory). On balance, the positive operating and financial momentum (record full-year results, subscription and market-share traction, improved operating efficiency and strengthened liquidity) outweigh the near-term challenges and risks.
Q4-2025 Updates
Positive Updates
Record Revenue and Strong Top-Line Growth
Q4 2025 revenue of $26.6M, up 29.6% year-over-year; full year 2025 revenue of $105.7M, up 35.4% versus 2024 and at the high end of guidance.
Subscription Momentum — Owlet360
Crossed over 110,000 paying Owlet360 subscribers (begin March); four consecutive quarters of sequential growth across paying subscribers, MRR, attach rate and retention; company expects subscription to become a larger portion of revenue throughout 2026.
Record Gross Margin and Adjusted EBITDA for Full Year
Full year 2025 gross margin was a record 50.6% (despite tariff headwinds); full year adjusted EBITDA was a record $2.0M, an improvement of $3.8M versus 2024.
Product Innovation and Commercial Momentum (Dream Sock, Dream Sight, Duo)
Launched Dream Sight camera (Sept 2025) with AI capabilities and new camera-specific subscription features planned; Dream Sock domestic sell-through +9% YoY and Duo sell-through +53% YoY; Dream Sock NPS = 77 and blended product NPS = 72.
Market Share and Channel Strength
Expanded share of total dollars spent on baby monitors to 41% in Q4 2025 (a 24% increase versus Q4 2024); registry additions for Dream Sock up 23% YoY across tracked registries (Amazon, Babylist, Target).
International Expansion and Regulatory Wins
Full year international revenue $19.2M, up 27% versus 2024; Q4 international sell-through strong with UK +58%, France +41%, Nordics +80% YoY; regulatory clearance secured for Dream Sock in India and approval for distribution in Israel; Dream Sock now sold in 31 countries with 7 regulatory clearances.
Improved Operating Efficiency and Unit Economics
Q4 operating expenses declined to $17.5M from $18.4M (improvement of $0.9M); operating expenses as a % of revenue improved to 66% from 90% in Q4 2024; revenue per FTE ~$1.0M; LTV to CAC ratio reported at 4.4 (company notes room to improve as subscription grows).
Stronger Balance Sheet and Liquidity
Cash and cash equivalents $35.5M (up from $23.8M in Q3 2025); paid down $12M on line of credit (balance $7M); $10M undrawn availability on LOC; total liquidity reported at $45.5M as of Dec 31, 2025.
2026 Financial Outlook
Full year 2026 guidance: revenue $126M–$130M (growth of 19%–23% over 2025), gross margin guidance 49%–52%, and adjusted EBITDA $3M–$5M (50%–150% growth over 2025); Q1 2026 guide: revenue $20M–$21M and gross margin 50%–52% (seasonally light quarter).
Negative Updates
Tariff Headwinds Impacting Margins and Profitability
Q4 2025 gross margin included a 510 basis point impact from tariffs; full year 2025 gross margin was impacted by tariffs by ~270 basis points; tariffs cited as the primary drag on Q4 adjusted EBITDA versus prior year.
Q4 Adjusted EBITDA and Quarterly Profitability Pressure
Q4 2025 adjusted EBITDA was $0.1M versus $0.5M in Q4 2024 (down sequentially due primarily to tariff costs), and Q1 2026 adjusted EBITDA is guided to be negative $2.5M to negative $1.5M.
Near-Term Revenue Seasonality and Q1 Guide Below Street Expectations
Q1 2026 revenue guide of $20M–$21M is light versus some expectations; company cites seasonality (Q1 is historically weakest), a difficult year-ago RSV/flu comp and retailer tightening of weeks of supply following softer consumer spending during holiday period.
Reported Net Loss and Ongoing Quarterly Losses
Q4 2025 net loss of $9.2M versus $9.1M in Q4 2024 (slightly worse year-over-year), indicating continued GAAP losses despite improving adjusted metrics.
International Q4 Revenue Timing and Operational Shift
Q4 international revenue declined year-over-year due primarily to an operational transition of Amazon U.K. to a direct import model that shifted revenue recognition from collection to delivery (pushing substantial U.K. sell-in from Q4 into Q1 2026).
External Uncertainty (Tariffs, Geopolitical Risk, Regulatory)
Management flagged continued uncertainty from volatile tariffs and the war in the Middle East; also noted prior FDA safety communication and ongoing regulatory complexity (no new FDA action reported but 'turmoil' at agency could affect future outcomes).
Company Guidance
Owlet guided Q1 2026 revenue of $20.0–$21.0 million, gross margins of 50%–52% and adjusted EBITDA of negative $2.5–$1.5 million (noting Q1 is seasonally the weakest quarter and lapping an unusually strong Q1 2025 driven by RSV/flu); for full-year 2026 they expect revenue of $126–$130 million (growth of 19%–23% vs. 2025’s $105.7M), gross margins of 49%–52% and adjusted EBITDA of $3–$5 million (up 50%–150% vs. 2025’s $2.0M), with revenue weighted roughly 40% in H1 and 60% in H2 as subscription becomes a larger portion of revenue; the outlook assumes continued tariff headwinds (~510 basis points per quarter) and does not bake in material contribution from new international markets or the OnCall telehealth rollout (both treated as upside).

Owlet Financial Statement Overview

Summary
Improving revenue growth and solid ~50% gross margins, plus a better-capitalized balance sheet with positive equity and modest debt. However, GAAP profitability and cash generation remain the key weaknesses, with continued net losses and negative operating/free cash flow indicating ongoing reliance on external capital.
Income Statement
38
Negative
Revenue growth improved meaningfully, accelerating from ~0.4% (2024) to ~6.1% (2025), and gross margin stayed solid around ~50% in both years. However, profitability remains the core issue: net losses persisted and widened in 2025 (net margin ~-39.6% vs. ~-16.1% in 2024), despite better operating losses than 2024. Overall, the company shows improving top-line momentum and stable product economics, but still lacks consistent path to net profitability.
Balance Sheet
45
Neutral
Leverage looks manageable on an absolute basis with total debt of ~$10.5M in 2025 and a moderate debt-to-equity ratio (~0.64) as equity turned positive (~$16.4M), a notable improvement from negative equity in 2022–2024. That said, the balance sheet has been volatile year-to-year (including periods of negative equity), and returns to shareholders remain deeply negative in 2025 given the net loss. Net-net: improving capitalization, but still not a consistently strong or stable equity story yet.
Cash Flow
30
Negative
Cash generation remains weak: operating cash flow and free cash flow were both negative in 2025 (about -$10.8M), following similarly negative levels in 2024 and worse burn in 2022–2023. While the cash burn appears to be trending down versus prior years, operating cash flow is still negative relative to reported losses, indicating the business has not yet reached self-funding operations. The key risk is continued reliance on external capital if losses and cash burn persist.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue105.70M78.06M54.01M69.20M75.84M
Gross Profit53.50M39.31M22.59M23.31M35.06M
EBITDA-7.80M-9.47M-27.49M-75.53M-42.71M
Net Income-41.90M-12.54M-32.90M-79.34M-71.70M
Balance Sheet
Total Assets85.60M49.52M44.12M58.10M140.05M
Cash, Cash Equivalents and Short-Term Investments35.50M20.25M16.56M11.23M95.05M
Total Debt10.50M11.87M16.39M18.30M16.53M
Total Liabilities50.20M70.66M73.80M68.74M84.86M
Stockholders Equity35.40M-21.15M-29.68M-10.63M55.19M
Cash Flow
Free Cash Flow-11.06M-11.97M-23.59M-82.94M-42.58M
Operating Cash Flow-10.80M-11.21M-23.53M-81.38M-40.56M
Investing Cash Flow-943.00K-761.00K-59.00K-1.56M-2.02M
Financing Cash Flow32.10M16.04M28.91M-878.00K120.62M

Owlet Technical Analysis

Technical Analysis Sentiment
Negative
Last Price5.14
Price Trends
50DMA
10.94
Negative
100DMA
11.78
Negative
200DMA
9.83
Negative
Market Momentum
MACD
-1.82
Positive
RSI
19.66
Positive
STOCH
9.22
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For OWLT, the sentiment is Negative. The current price of 5.14 is below the 20-day moving average (MA) of 8.42, below the 50-day MA of 10.94, and below the 200-day MA of 9.83, indicating a bearish trend. The MACD of -1.82 indicates Positive momentum. The RSI at 19.66 is Positive, neither overbought nor oversold. The STOCH value of 9.22 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OWLT.

Owlet Risk Analysis

Owlet disclosed 73 risk factors in its most recent earnings report. Owlet reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Owlet Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$121.47M-2.59-103.93%-20.10%7.87%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
46
Neutral
$106.84M-2.75-68.83%16.63%10.43%
46
Neutral
$57.44M-1.67-82.79%15.59%4.13%
45
Neutral
$70.59M-10.02532.96%21.02%-200.88%
43
Neutral
$144.74M-217.35239.66%26.83%-52.47%
43
Neutral
$187.40M-10.76-55.72%-4.39%11.70%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
OWLT
Owlet
5.14
1.20
30.46%
LUNG
Pulmonx
1.36
-6.01
-81.55%
LNSR
LENSAR
5.91
-8.33
-58.50%
HYPR
Hyperfine
1.24
0.41
49.40%
SGHT
Sight Sciences
3.47
0.40
13.03%
RPID
Rapid Micro Biosystems
2.35
-0.29
-10.98%

Owlet Corporate Events

Legal Proceedings
Owlet Awaits Court Decision on Derivative Settlement
Negative
Feb 5, 2026

Owlet has notified investors that the U.S. District Court for the Central District of California has rescheduled the hearing to consider a proposed settlement of consolidated shareholder derivative litigation, In re Owlet, Inc. Shareholder Derivative Litigation, from February 6, 2026 to February 25, 2026. The underlying derivative actions, initially filed in August and October 2024, allege breaches of fiduciary duty, unjust enrichment, abuse of control, waste of corporate assets and violations of Section 14(a) of the Exchange Act by current and former directors and officers, and were consolidated after related securities class action claims moved toward settlement. Following months of arm’s-length negotiations, document exchanges and settlement proposals through March 2025, the parties reached an agreement in principle on corporate governance and internal control reforms that they say will provide substantial benefits to Owlet and current shareholders, with the upcoming hearing intended to determine whether the settlement terms, including governance reforms and plaintiffs’ fees and service awards, are fair, reasonable and adequate, which could bring greater governance stability but leaves no monetary recovery for individual stockholders.

The most recent analyst rating on (OWLT) stock is a Hold with a $12.50 price target. To see the full list of analyst forecasts on Owlet stock, see the OWLT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 13, 2026